Home/Filings/4/0000950170-24-131499
4//SEC Filing

Zakrzewski Joseph S 4

Accession 0000950170-24-131499

CIK 0001880438other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:16 PM ET

Size

5.2 KB

Accession

0000950170-24-131499

Insider Transaction Report

Form 4
Period: 2024-11-27
Transactions
  • Purchase

    Common Stock

    2024-11-27$1.40/sh+2,000$2,800125,199 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    405,880
Footnotes (1)
  • [F1]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Documents

1 file

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001331852

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:16 PM ET
Size
5.2 KB